The FDA's CVM is asking veterinarians and animal care retailers to educate people on the harms of using this animal drug to ultimately, help prevent more people from falling ill.
As reported in several recent news stories including a Health Alert1 from the US Centers for Disease Control and Prevention (CDC), poison control centers nationwide are noticing a surge in people experiencing adverse health effects and becoming severely sick after taking animal ivermectin.
The FDA’s Center for Veterinary Medicine (CVM) is ongoingly concerned with people utilizing animal formulations of ivermectin to treat or prevent COVID-19 and is urging veterinarians and retailers to spread public awareness about the dangerous effects this drug has on humans.
According to a CVM Letter,2 People are buying various highly concentrated animal ivermectin drug formulations including “pour-on,” injectable, paste, and “drench” that are intended for horses, cattle, and sheep.
Though some animal drugs have the same active ingredient as an approved human drug, animal drugs have not been evaluated for human safety or effectiveness. Using veterinary drugs for human conditions can be dangerous as the drug may be completely infective or could worsen the illness and/or lead to serious, potentially life-threatening health complications.2 Additionally, humans should not take drugs approved for veterinary use, “for research only,” or otherwise not for human consumption.
To help veterinarians and retailers inform the public, the CVM has created a downloadable sign to pass out or post at a place of business that helps elucidate the perils of taking this drug for human use.
In certain parts of the country, there has been limited availability of animal ivermectin products. If you are a veterinarian or animal caretaker and are struggling to obtain this drug for animal use, the CVM suggests emailing: AnimalDrugShortages@fda.hhs.gov.
To help protect public health, the CVM also asks that you report any animal drug advertising/animal ivermectin products with statements about preventing or treating COVID-19 by emailing: FDA-COVID-19-Fraudulent-Products@fda.hhs.gov or calling 1-888-InfoFDA (1-888-463-6332).
Reference
Proposed midlevel role poses unacceptable risks
October 30th 2024Proposals that would create a new midlevel practitioner (MLP) role raise serious concerns about the future of quality care for veterinary patients. Sometimes referred to as a veterinary professional associate (VPA), their duties would overlap those of a veterinarian and veterinary technician.
Read More